1 Chinese Herbal Medicine and Acupuncture Reduced the Risk of Stroke After Bell's Palsy: A Population-Based Retrospective Cohort Study.

2 Birth weight discordance in very low birth weight twins: mortality, morbidity, and neurodevelopment.

3 Esophageal tuberculosis with coexisting opportunistic infections in a renal allograft transplant recipient.

4 New Progress in Azole Compounds as Antimicrobial Agents.

5 Response to "Reply to 'Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients': To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out".

6 Sars-Cov-2 hurricane impacting proctology outpatient clinics and proctologic emergencies. On the verge of phase 2, learning from phase 1. Correspondence.

7 diagnóstico laboratorial da infecção pelo vírus herpes simples (hsv) em pacientes transplantados e não-transplantados laboratorial diagnosis of herpes simplex virus infection (hsv) in transplanted and non-transplanted patients

8 toxicology and biodistribution studies for mgh2.1, an oncolytic virus that expresses two prodrug-activating genes, in combination with prodrugs

9 modulation of the intratumoral immune landscape by oncolytic herpes simplex virus virotherapy

10 infection and transport of herpes simplex virus type 1 in neurons: role of the cytoskeleton

11 balticolid: a new 12-membered macrolide with antiviral activity from an ascomycetous fungus of marine origin

12 a novel method to titrate herpes simplex virus-1 (hsv-1) using laser-based scanning of near-infrared fluorophores conjugated antibodies

13 Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses.

14 Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

15 A Rare Case of Herpes Simplex Virus-2 Hepatitis with Negative Serology

16 Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

17 Epidemiology of Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and herpes simplex virus type 2 among female sex workers in the Middle East and North Africa: systematic review and meta-analytics

18 Herpes simplex virus type 1 epidemiology in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions

19 Functional interactions between herpes simplex virus pUL51, pUL7 and gE reveal cell-specific mechanisms for epithelial cell-to-cell spread.

20 Multilevel Measures of Education and Pathways to Incident Herpes Simplex Virus Type 2 in Adolescent Girls and Young Women in South Africa.

21 Applicability of molecular assays for detection and typing of herpes simplex viruses in encephalitis cases.

22 Identification and Visualization of Functionally Important Domains and Residues in Herpes Simplex Virus Glycoprotein K(gK) Using a Combination of Phylogenetics and Protein Modeling.

23 Cold atmospheric plasma as antiviral therapy - effect on human herpes simplex virus type 1.

24 Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy

25 Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis

26 Neonatal herpes simplex virus infection in King County, Washington. Increasing incidence and epidemiologic correlates

27 Serological Testing for Herpes Simplex Virus (HSV)–1 and HSV-2 Infection

28 Recommendations for the Selective Use of Herpes Simplex Virus Type 2 Serological Tests

29 The impact of active herpes simplex virus infection on human immunodeficiency virus load

30 Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons

31 Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis

32 Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression

33 The acquisition of herpes simplex virus during pregnancy

34 Effect of Serologic Status and Cesarean Delivery on Transmission Rates of Herpes Simplex Virus From Mother to Infant

35 Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing

36 A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group

37 Estimating Neonatal Herpes Simplex Virus Incidence and Mortality Using Capture-recapture, Florida

38 Herpes simplex virus type 2 in the United States, 1976 to 1994

39 Transcription of the Herpes Simplex Virus 1 Genome during Productive and Quiescent Infection of Neuronal and Nonneuronal Cells

40 Frequent Recovery of HIV-1 From Genital Herpes Simplex Virus Lesions in HIV-1–Infected Men

41 Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial

42 The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995

43 An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes

44 The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2

45 Changing presentation of herpes simplex virus infection in neonates

46 Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment

47 Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections

48 Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women

49 Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers

50 Management of Herpes Simplex Virus Type 2 Infection in HIV Type 1–Infected Persons

51 Changing Presentation of Herpes Simplex Virus Infection in Neonates

52 Herpes simplex virus

53 Neonatal Herpes Simplex Virus Infection in King County, Washington: Increasing Incidence and Epidemiologic Correlates

54 Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals

55 Development of an Innovative Real-World Evidence Registry for the Herpes Simplex Virus: Case Study

56 Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men

57 Herpes Simplex Virus Infection as a Risk Factor for Human Immunodeficiency Virus Infection in Heterosexuals

58 Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant

59 National surveillance for neonatal herpes simplex virus infections

60 Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

61 Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2

62 Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men

63 Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women

64 Psychological and psychosexual implications of herpes simplex virus infections

65 Testing for type-specific antibody to herpes simplex virus--implications for clinical practice

66 Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling

67 Testing for type-specific antibody to herpes simplex virus—implications for clinical practice

68 crispr/cas9 mutagenesis of ul21 in multiple strains of herpes simplex virus reveals differential requirements for pul21 in viral replication

69 seroprevalence of herpes simplex virus infection in hiv coinfected individuals in eastern india with risk factor analysis

70 kinetic approaches to understanding the mechanisms of fidelity of the herpes simplex virus type 1 dna polymerase

71 coinfection with rickettsia helvetica and herpes simplex virus 2 in a young woman with meningoencephalitis

72 the management of herpes simplex virus infections in hiv infected patients: current issues and the role of cidofovir

73 immunopathogenic role of herpes simplex virus in behçet’s disease

74 herpes simplex virus bronchiolitis in a cannabis user

75 clinical and laboratory findings that differentiate herpes simplex virus central nervous system disease from enteroviral meningitis

76 association between herpes simplex virus type 2 (hsv 2) and bad obstetric outcomes

77 pityriasis lichenoides chronica associated with herpes simplex virus type 2

78 contribution of ms-based proteomics to the understanding of herpes simplex virus type 1 interaction with host cells

79 impacto do laser de baixa intensidade na supressão de infecções pelos vírus herpes simplex 1 e 2: estudo in vitro impact of low-intensity laser on the suppression of infections caused by herpes simplex viruses 1 and 2: in vitro study

80 a case of hypertrophic herpes simplex virus affecting the eyelid and cornea masquerading as igg4-related disease

81 Risk of Human Immunodeficiency Virus Infection in Herpes Simplex Virus Type 2–Seropositive Persons: A Meta-analysis

82 Faculty Opinions Recommended Article: Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

Keyword Connections

Journals

Research Groups

Bibliographies